* Cellebrite DI Ltd CLBT.OQ CLBT.O is expected to show a
rise
in quarterly revenue when it reports results on February 15.
* The Petah Tikva Israel-based company is expected to
report a
9.8% increase in revenue to $74.53 million from $67.91 million a
year ago, according to the mean estimate from 5 analysts, based
on Refinitiv data.
* Refinitiv's mean analyst estimate for Cellebrite DI Ltd
is for
earnings of 4 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Cellebrite
DI Ltd
is $6.5, above its last closing price of $5.09.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Sep. 30 2022 0.02 0.02 0.01 Missed -55.6
Jun. 30 2022 0.02 0.03 0.00 Missed -100
Mar. 31 2022 0.02 0.02 0.01 Missed -55.6
Dec. 31 2021 0.02 0.02 0.03 Beat 33.3
Sep. 0.02 0.02 0.08 Beat 300
30 2021
This summary was machine generated February 13 at 14:51 GMT.
All figures in US dollars unless otherwise stated